Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kineta Inc KA

Healthcare Biotechnology
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a... see more

Recent & Breaking News (NDAQ:KA)

Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 3, 2021

Yumanity Therapeutics to Present at Multiple Upcoming November Investor Conferences

GlobeNewswire November 16, 2021

Yumanity Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

GlobeNewswire November 15, 2021

Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 12, 2021

Yumanity Therapeutics Announces Positive Top-Line Results of Phase 1b Clinical Trial for YTX-7739 in Patients with Parkinson's Disease; Company Plans to Advance Program to Phase 2

GlobeNewswire November 10, 2021

Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 14, 2021

Yumanity Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 9, 2021

Yumanity Therapeutics to Present at the H.C. Wainwright 23rd Global Investment Conference

GlobeNewswire September 9, 2021

Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants

GlobeNewswire August 16, 2021

Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio

PR Newswire December 22, 2020

Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis

GlobeNewswire December 15, 2020

Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - MVC, PTI, CGIX, STND

GlobeNewswire December 1, 2020

WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations

PR Newswire November 30, 2020

Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - GLIBA, CBMG, MVC, PTI

GlobeNewswire November 25, 2020

WeissLaw LLP Reminds PTI, MVC, and EIDX Shareholders About Its Ongoing Investigations

PR Newswire November 23, 2020

Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results

PR Newswire November 16, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm - CBMG, MVC, PTI, CGIX

GlobeNewswire November 13, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds BMHC, SFBK, WPX, and PTI Shareholders About Its Ongoing Investigations

PR Newswire November 13, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm - MVC, WPX, PTI, SBPH

GlobeNewswire November 7, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds PTI, BMCH, and MOBL Shareholders About Its Ongoing Investigations

PR Newswire November 6, 2020